Cite
HARVARD Citation
Wissing, M. et al. (2013). Targeting prostate cancer cell lines with polo‐like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors. FASEB journal. 27 (10), pp. 4279-4293. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wissing, M. et al. (2013). Targeting prostate cancer cell lines with polo‐like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors. FASEB journal. 27 (10), pp. 4279-4293. [Online].